These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 36672326)

  • 1. The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited.
    Dzobo K; Senthebane DA; Dandara C
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment.
    Frisbie L; Buckanovich RJ; Coffman L
    Stem Cells; 2022 Aug; 40(8):705-715. PubMed ID: 35583414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours.
    Bigos KJ; Quiles CG; Lunj S; Smith DJ; Krause M; Troost EG; West CM; Hoskin P; Choudhury A
    Front Oncol; 2024; 14():1331355. PubMed ID: 38352889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the microenvironment in solid tumors.
    Belli C; Trapani D; Viale G; D'Amico P; Duso BA; Della Vigna P; Orsi F; Curigliano G
    Cancer Treat Rev; 2018 Apr; 65():22-32. PubMed ID: 29502037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategies.
    Wei J; Yao J; Yan M; Xie Y; Liu P; Mao Y; Li X
    Acta Biomater; 2022 Sep; 150():34-47. PubMed ID: 35948177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal cells in the tumor microenvironment: accomplices of tumor progression?
    Zhao Y; Shen M; Wu L; Yang H; Yao Y; Yang Q; Du J; Liu L; Li Y; Bai Y
    Cell Death Dis; 2023 Sep; 14(9):587. PubMed ID: 37666813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Obesity, Adipose Tissue, and Tumor Microenvironment on Macrophage Polarization and Metastasis.
    Habanjar O; Diab-Assaf M; Caldefie-Chezet F; Delort L
    Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communicator Extraordinaire: Extracellular Vesicles in the Tumor Microenvironment Are Essential Local and Long-Distance Mediators of Cancer Metastasis.
    Mitchell MI; Loudig O
    Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.
    Jarboe T; Tuli NY; Chakraborty S; Maniyar RR; DeSouza N; Xiu-Min Li ; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():1-31. PubMed ID: 34888842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment.
    Fridman ES; Ginini L; Gil Z
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
    Pradip D; Jennifer A; Nandini D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Tumor Microenvironment for Cancer Therapy.
    Roma-Rodrigues C; Mendes R; Baptista PV; Fernandes AR
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins.
    Zeltz C; Primac I; Erusappan P; Alam J; Noel A; Gullberg D
    Semin Cancer Biol; 2020 May; 62():166-181. PubMed ID: 31415910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.